Fintel reports that on August 15, 2024, JP Morgan downgraded their outlook for bluebird bio (MUN:BLE) from Overweight to Neutral.
Analyst Price Forecast Suggests 52.97% Downside
As of December 21, 2023, the average one-year price target for bluebird bio is 7,48 €/share. The forecasts range from a low of 3,03 € to a high of 10,50 €. The average price target represents a decrease of 52.97% from its latest reported closing price of 15,90 € / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for bluebird bio is 50MM. The projected annual non-GAAP EPS is -11.73.
What is the Fund Sentiment?
There are 298 funds or institutions reporting positions in bluebird bio. This is an decrease of 34 owner(s) or 10.24% in the last quarter. Average portfolio weight of all funds dedicated to BLE is 0.03%, an increase of 9.35%. Total shares owned by institutions decreased in the last three months by 25.72% to 98,465K shares.
What are Other Shareholders Doing?
Ameriprise Financial holds 6,392K shares representing 3.32% ownership of the company. In its prior filing, the firm reported owning 6,392K shares , representing a decrease of 0.01%. The firm decreased its portfolio allocation in BLE by 86.32% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 6,058K shares representing 3.14% ownership of the company. In its prior filing, the firm reported owning 6,048K shares , representing an increase of 0.15%. The firm decreased its portfolio allocation in BLE by 15.31% over the last quarter.
LACAX - Columbia Acorn Fund holds 5,366K shares representing 2.78% ownership of the company. In its prior filing, the firm reported owning 2,316K shares , representing an increase of 56.85%. The firm increased its portfolio allocation in BLE by 103.89% over the last quarter.
Millennium Management holds 5,147K shares representing 2.67% ownership of the company. In its prior filing, the firm reported owning 6,240K shares , representing a decrease of 21.23%. The firm decreased its portfolio allocation in BLE by 31.24% over the last quarter.
IWM - iShares Russell 2000 ETF holds 4,660K shares representing 2.42% ownership of the company. In its prior filing, the firm reported owning 2,819K shares , representing an increase of 39.52%. The firm increased its portfolio allocation in BLE by 57.93% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
